Under the new clearance, the Propeller system can now be used to help predict exacerbations in patients with asthma and COPD.
People with any chronic respiratory disease and their family caregivers can get personalized inhaler technique coaching and answers to their questions.
Safeguard Scientifics led the round, which will be used to accelerate product development, strategic alliances, client services, sales and marketing.
FDA-approved marketing claims of improved adherence and reduction in exacerbations address key unmet needs in respiratory health.
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.
The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.
Patients will have the opportunity to enroll in a new program to determine how Propeller's hi-tech tool can impact adherence rates and patient engagement.
The study demonstrated effectiveness of the Propeller Health Asthma Management Platform to better manage chronic respiratory disease.
The initial focus of the collaboration will be the development of an add-on sensor for Vectura's lever-operated multi-dose inhaler (LOMI).
The new custom sensors will allow for passively recording compliance data, better informing patients and their physicians of adherence and other factors.
12Page 1 of 2